Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
Stephen J. Kent*, Anne Zhao, Susan J. Best, Jenalle D. Chandler, David B. Boyle, Ian A. Ramshaw
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
334
Citations
(Scopus)